BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28176546)

  • 1. Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit.
    Mohammed A; Gbonjubola VA; Koorbanally NA; Islam MS
    Pharm Biol; 2017 Dec; 55(1):1010-1016. PubMed ID: 28176546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHYTOCHEMISTRY, ANTIOXIDATIVE ACTIVITY AND INHIBITION OF KEY ENZYMES LINKED TO TYPE 2 DIABETES BY VARIOUS PARTS OF AFRAMOMUM MELEGUETA IN VITRO.
    Mohammed A; Koorbanally NA; Islam MS
    Acta Pol Pharm; 2016; 73(2):403-17. PubMed ID: 27180433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves.
    Poongunran J; Perera HK; Jayasinghe L; Fernando IT; Sivakanesan R; Araya H; Fujimoto Y
    Pharm Biol; 2017 Dec; 55(1):206-211. PubMed ID: 27927056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleanolic acid as a potential antidiabetic component of
    Mohammed A; Victoria Awolola G; Ibrahim MA; Anthony Koorbanally N; Islam MS
    Nat Prod Res; 2021 Mar; 35(5):788-791. PubMed ID: 30990061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
    Ibrahim MA; Koorbanally NA; Islam MS
    Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethyl acetate fraction of Aframomum melegueta fruit ameliorates pancreatic β-cell dysfunction and major diabetes-related parameters in a type 2 diabetes model of rats.
    Mohammed A; Koorbanally NA; Islam MS
    J Ethnopharmacol; 2015 Dec; 175():518-27. PubMed ID: 26456345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices.
    Adefegha SA; Oboh G
    Pharm Biol; 2012 Jul; 50(7):857-65. PubMed ID: 22480175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro antidiabetic and antioxidant characterizations of Elettaria cardamomum (L.) Maton (Zingiberaceae), Piper cubeba L. f. (Piperaceae), and Plumeria rubra L. (Apocynaceae).
    Ahmed AS; Ahmed Q; Saxena AK; Jamal P
    Pak J Pharm Sci; 2017 Jan; 30(1):113-126. PubMed ID: 28603121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anacardium humile St. Hil as a novel source of antioxidant, antiglycation and α-amylase inhibitors molecules with potential for management of oxidative stress and diabetes.
    Lima Júnior JP; Franco RR; Saraiva AL; Moraes IB; Espindola FS
    J Ethnopharmacol; 2021 Mar; 268():113667. PubMed ID: 33301920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
    Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
    J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized Emblica officinalis fruit extract inhibited the activities of α-amylase, α-glucosidase, and dipeptidyl peptidase-4 and displayed antioxidant potential.
    Majeed M; Majeed S; Mundkur L; Nagabhushanam K; Arumugam S; Beede K; Ali F
    J Sci Food Agric; 2020 Jan; 100(2):509-516. PubMed ID: 31487036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of In Vitro α-Amylase and α-Glucosidase Inhibitory Potentials of 14 Medicinal Plants Constituted in Thai Folk Antidiabetic Formularies.
    Somtimuang C; Olatunji OJ; Ovatlarnporn C
    Chem Biodivers; 2018 Apr; 15(4):e1800025. PubMed ID: 29460340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose-lowering effect of Tectona grandis flowers in type 2 diabetic rats: a study on identification of active constituents and mechanisms for antidiabetic action.
    Ramachandran S; Rajasekaran A
    J Diabetes; 2014 Sep; 6(5):427-37. PubMed ID: 24393489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
    Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
    Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Panigrahy SK; Kumar A; Bhatt R
    J Diet Suppl; 2020; 17(1):81-87. PubMed ID: 30325249
    [No Abstract]   [Full Text] [Related]  

  • 17. Boerhaavia diffusa inhibits key enzymes linked to type 2 diabetes in vitro and in silico; and modulates abdominal glucose absorption and muscle glucose uptake ex vivo.
    Oyebode OA; Erukainure OL; Chukwuma CI; Ibeji CU; Koorbanally NA; Islam S
    Biomed Pharmacother; 2018 Oct; 106():1116-1125. PubMed ID: 30119178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fruit, vegetables, and mushrooms for the preparation of extracts with α-amylase and α-glucosidase inhibition properties: A review.
    Papoutsis K; Zhang J; Bowyer MC; Brunton N; Gibney ER; Lyng J
    Food Chem; 2021 Feb; 338():128119. PubMed ID: 33091976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of α-glucosidase inhibition by different fractions of three species of Labiatae extracts: a new diabetes treatment model.
    Rouzbehan S; Moein S; Homaei A; Moein MR
    Pharm Biol; 2017 Dec; 55(1):1483-1488. PubMed ID: 28367665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.